Global Custom Market Research Reports Provider Company

phone

Reata Pharmaceuticals Inc (RETA) - Financial and Strategic SWOT Analysis Review

  • Published Date: 13 Nov 2017
  • Number of Pages: 25
  • Category: Healthcare and Medical
  • Country: United States of America
Summary

Reata Pharmaceuticals Inc (RPI) is a clinical-stage biopharmaceutical company that develops novel therapeutics for the treatment of rare and life-threatening diseases. The company develops drugs in various therapeutic areas such as cardiovascular, ophthalmology, immune-oncology, and rare diseases. Its lead product candidate include bardoxolone methyl, which is used for the treatment of pulmonary arterial hypertension and pulmonary hypertension; and omaveloxolone, which helps in the treatment of melanoma and various diseases. The company works in partnership with academics, biotechnology and pharmaceutical companies to develop technologies which target core patho-physiological processes required in driving intractable diseases. RPI is headquartered in Irving, Texas, the US.

Reata Pharmaceuticals Inc Key Recent Developments

Aug 14,2017: Reata Pharmaceuticals Announces Second Quarter 2017 Financial and Operating Results
May 11,2017: Reata pharmaceuticals announces first quarter 2017 financial and operating results
Apr 03,2017: Reata Pharmaceuticals Secures $35 Million Term Loan Facility
Mar 24,2017: Reata Pharmaceuticals Appoints David Chapman as Vice President, Marketing
Mar 03,2017: Reata Pharmaceuticals Announces Fourth Quarter and Full Year 2016 Financial and Operating Results

This comprehensive SWOT profile of Reata Pharmaceuticals Inc provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Reata Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,



- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief Summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.



Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,



You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.



Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.



Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.



Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.



Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData
Table of Contents


Section 1 - About the Company



Reata Pharmaceuticals Inc - Key Information

Reata Pharmaceuticals Inc - Overview

Reata Pharmaceuticals Inc - Key Employees

Reata Pharmaceuticals Inc - Key Employee Biographies

Reata Pharmaceuticals Inc - Key Operational Heads

Reata Pharmaceuticals Inc - Major Products and Services

Reata Pharmaceuticals Inc - History

Reata Pharmaceuticals Inc - Company Statement

Reata Pharmaceuticals Inc - Locations And Subsidiaries

Reata Pharmaceuticals Inc - Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries



Section 2 - Company Analysis



Reata Pharmaceuticals Inc - Business Description

Reata Pharmaceuticals Inc - Corporate Strategy

Reata Pharmaceuticals Inc - SWOT Analysis

SWOT Analysis - Overview

Reata Pharmaceuticals Inc - Strengths

Reata Pharmaceuticals Inc - Weaknesses

Reata Pharmaceuticals Inc - Opportunities

Reata Pharmaceuticals Inc - Threats

Reata Pharmaceuticals Inc - Key Competitors



Section 3 - Company Financial Performance Charts



Reata Pharmaceuticals Inc - Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts



Section 4 - Appendix



Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer





Note*: Some sections may be missing if data is unavailable for the company

List Of Tables




Reata Pharmaceuticals Inc, Key Information

Reata Pharmaceuticals Inc, Key Ratios

Reata Pharmaceuticals Inc, Share Data

Reata Pharmaceuticals Inc, Major Products and Services

Reata Pharmaceuticals Inc, History

Reata Pharmaceuticals Inc, Key Employees

Reata Pharmaceuticals Inc, Key Employee Biographies

Reata Pharmaceuticals Inc, Key Operational Heads

Reata Pharmaceuticals Inc, Other Locations

Reata Pharmaceuticals Inc, Subsidiaries

Reata Pharmaceuticals Inc, Key Manufacturing facilities

Reata Pharmaceuticals Inc, Key Competitors

Reata Pharmaceuticals Inc, SWOT Analysis

Reata Pharmaceuticals Inc, Ratios based on current share price

Reata Pharmaceuticals Inc, Annual Ratios

Reata Pharmaceuticals Inc, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures




Reata Pharmaceuticals Inc, Performance Chart

Reata Pharmaceuticals Inc, Ratio Charts

Reata Pharmaceuticals Inc (RPI) is a clinical-stage biopharmaceutical company that develops novel therapeutics for the treatment of rare and life-threatening diseases. The company develops drugs in various therapeutic areas such

View Report

Reata Pharmaceuticals Inc (RPI) is a clinical-stage biopharmaceutical company that develops novel therapeutics for the treatment of rare and life-threatening diseases. The company develops drugs in various therapeutic areas such

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports